NICOLE SHUERT: Open Payments
NPI 1942532445 · ST. LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 13 payments from 8 companies in 2025. Trend: 2023 $152 · 2024 $221 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 3 | $70 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $43 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $19 |
| Exeltis, USA Inc. | 1 | $13 |
Products named: NEXPLANON, MYFEMBREE, Veozah, Phexxi, ZURZUVAE, Lynkuet, SLYND.
Industry payments across MO — which companies pay providers there.
